Details for Patent: 12,296,047
Which drugs does patent 12,296,047 protect, and when does it expire?
Patent 12,296,047 protects EXPAREL and is included in one NDA.
This patent has fourteen patent family members in eight countries.
Summary for Patent: 12,296,047
| Title: | Manufacturing of bupivacaine multivesicular liposomes |
| Abstract: | Embodiments of the present application relate to compositions bupivacaine multivesicular liposomes (MVLs) prepared by a commercial manufacturing process with large particle diameter span. |
| Inventor(s): | Jeffrey S. Hall, David J. Turnbull, John J. Grigsby, Jr., Soroush M. Ardekani, Kathleen D. A. Los |
| Assignee: | Pacira Pharmaceuticals Inc |
| Application Number: | US18/943,310 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 12,296,047 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 12,296,047
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-001 | Oct 28, 2011 | RX | Yes | Yes | 12,296,047 | ⤷ Start Trial | Y | METHOD OF TREATING PAIN, FOR EXAMPLE, VIA INFILTRATION TO PROVIDE LOCAL ANALGESIA OR VIA A NERVE BLOCK TO PROVIDE REGIONAL ANALGESIA | ⤷ Start Trial | |||
| Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-002 | Oct 28, 2011 | RX | Yes | Yes | 12,296,047 | ⤷ Start Trial | Y | METHOD OF TREATING PAIN, FOR EXAMPLE, VIA INFILTRATION TO PROVIDE LOCAL ANALGESIA OR VIA A NERVE BLOCK TO PROVIDE REGIONAL ANALGESIA | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,296,047
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| China | 114209654 | ⤷ Start Trial | |||
| Denmark | 4032528 | ⤷ Start Trial | |||
| European Patent Office | 4032528 | ⤷ Start Trial | |||
| European Patent Office | 4740937 | ⤷ Start Trial | |||
| Spain | 3073947 | ⤷ Start Trial | |||
| Finland | 4032528 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
